Stockreport

NeoGenomics to Present RaDaR ST Bridging Study at ISLB 2025, Demonstrating Reliable MRD Detection Across Solid Tumors

NeoGenomics, Inc.  (NEO) 
Last neogenomics, inc. earnings: 4/28 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: ir.neogenomics.com
PDF Additional presentations to focus on liquid biopsy– MRD based detection and genomic profiling across solid tumors FORT MYERS, Fla.--(BUSINESS WIRE)--NeoGenomics, Inc. [Read more]